Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
  • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
  • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
  • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
  • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
  • A61K31/4035—Isoindoles, e.g. phthalimide
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
  • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
  • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
  • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
  • C07D239/52—Two oxygen atoms
  • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
  • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
  • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Immunology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Epidemiology (AREA)
• Transplantation (AREA)
• Rheumatology (AREA)
• Pain & Pain Management (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)
• Soft Magnetic Materials (AREA)
• Indole Compounds (AREA)
• Macromonomer-Based Addition Polymer (AREA)
• Anti-Oxidant Or Stabilizer Compositions (AREA)
• Plural Heterocyclic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Lubricants (AREA)
• Adhesives Or Adhesive Processes (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=29227079

Family Applications (1)

Country Status (28)

Families Citing this family (11)

Family Cites Families (21)

• 2003
  • 2003-09-13 GB GBGB0321538.1A patent/GB0321538D0/en not_active Ceased
• 2004
  • 2004-09-10 AT AT08163972T patent/ATE502922T1/de not_active IP Right Cessation
  • 2004-09-10 MX MXPA06002458A patent/MXPA06002458A/es active IP Right Grant
  • 2004-09-10 DK DK04765231T patent/DK1663970T3/da active
  • 2004-09-10 AU AU2004272280A patent/AU2004272280C1/en not_active Ceased
  • 2004-09-10 NZ NZ545211A patent/NZ545211A/en not_active IP Right Cessation
  • 2004-09-10 KR KR1020067005114A patent/KR20060120648A/ko not_active Ceased
  • 2004-09-10 PT PT04765231T patent/PT1663970E/pt unknown
  • 2004-09-10 HR HR20080668T patent/HRP20080668T3/xx unknown
  • 2004-09-10 KR KR1020127000264A patent/KR20120007566A/ko not_active Ceased
  • 2004-09-10 RU RU2006106850/04A patent/RU2370488C2/ru not_active IP Right Cessation
  • 2004-09-10 EP EP10176905A patent/EP2295408A1/en not_active Withdrawn
  • 2004-09-10 BR BRPI0413791-4A patent/BRPI0413791A/pt not_active IP Right Cessation
  • 2004-09-10 ES ES04765231T patent/ES2314436T3/es not_active Expired - Lifetime
  • 2004-09-10 AT AT04765231T patent/ATE413384T1/de active
  • 2004-09-10 SG SG200805432-2A patent/SG145685A1/en unknown
  • 2004-09-10 US US10/571,443 patent/US7601729B2/en not_active Expired - Fee Related
  • 2004-09-10 EP EP08163972A patent/EP2042488B1/en not_active Expired - Lifetime
  • 2004-09-10 EP EP04765231A patent/EP1663970B1/en not_active Expired - Lifetime
  • 2004-09-10 SI SI200431008T patent/SI1663970T1/sl unknown
  • 2004-09-10 PL PL04765231T patent/PL1663970T3/pl unknown
  • 2004-09-10 WO PCT/EP2004/010319 patent/WO2005026120A1/en not_active Ceased
  • 2004-09-10 CN CN200480026229.7A patent/CN1849306B/zh not_active Expired - Fee Related
  • 2004-09-10 CA CA2538315A patent/CA2538315C/en not_active Expired - Fee Related
  • 2004-09-10 DE DE602004031991T patent/DE602004031991D1/de not_active Expired - Lifetime
  • 2004-09-10 KR KR1020137014317A patent/KR20130079628A/ko not_active Ceased
  • 2004-09-10 ES ES08163972T patent/ES2362954T3/es not_active Expired - Lifetime
  • 2004-09-10 DE DE602004017622T patent/DE602004017622D1/de not_active Expired - Lifetime
  • 2004-09-10 JP JP2006525794A patent/JP2007505081A/ja active Pending
  • 2004-09-10 NZ NZ573479A patent/NZ573479A/en not_active IP Right Cessation
• 2006
  • 2006-01-23 IL IL173305A patent/IL173305A/en not_active IP Right Cessation
  • 2006-01-26 IS IS8268A patent/IS2622B/is unknown
  • 2006-02-02 NO NO20060540A patent/NO20060540L/no not_active Application Discontinuation
  • 2006-03-10 ZA ZA200602070A patent/ZA200602070B/en unknown
  • 2006-03-14 MA MA28873A patent/MA28039A1/fr unknown
• 2008
  • 2008-11-07 US US12/266,767 patent/US8263602B2/en not_active Expired - Fee Related
  • 2008-11-26 RU RU2008146479/04A patent/RU2008146479A/ru not_active Application Discontinuation
• 2009
  • 2009-01-27 CY CY20091100090T patent/CY1109400T1/el unknown
  • 2009-08-19 IS IS8843A patent/IS8843A/is unknown
  • 2009-09-01 US US12/551,892 patent/US8343986B2/en not_active Expired - Fee Related
• 2011
  • 2011-06-14 JP JP2011132261A patent/JP2011231118A/ja not_active Withdrawn
• 2012
  • 2012-01-25 JP JP2012012663A patent/JP2012107031A/ja active Pending

Also Published As

Similar Documents